We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
UK government response to the independent report: 'Menopause and the Workplace: How to enable fulfilling working lives'.
A serious shortage protocol (SSP) has been issued across the UK for Utrogestan® 100mg capsules today (19 May 2023).
Women in England are being encouraged to help shape reproductive health policy by sharing their experiences, as the government launches a landmark survey.
NDA achieves Menopause Friendly Accreditation in recognition of its work to put support in place for colleagues affected by menopause.
Guidance to help recruit, support and retain women experiencing menopause and stop women considering giving up their employment.
A year on from its Women’s Health Strategy, the government has announced a package of new measures to boost the health and wellbeing of women and girls.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.